Abstract
In the course of screening anti-dementia agents from natural products, two β-secretase (BACE1) inhibitors were isolated from the ethyl acetate soluble fraction of Sanguisorbae Radix by the activity-guided purification using silica gel, Sephadex LH-20, and RP-HPLC. They were identified as 1,2,3-trigalloyl-4,6-hexahydroxydiphenoyl-β-d-glucopyranoside (Tellimagrandin II,1) and 1,2,3,4,6-pentagalloyl-β-d-glucopyranoside (2) and were shown to non-competitively inhibit β-secretase (BACE1) with the IC50 values of 3.10×10−6 M and 3.76×10−6 M, respectively. TheKi values of1 and2 were 6.84×10−6 M and 5.13×10−6 M. They were less inhibitory to α-secretase (TACE) and other serine proteases such as chymotrypsin, trypsin, and elastase, suggesting that they were relatively specific inhibitors of BACE1.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., and Doan, M.et al., Purification and cloning of amyloid precursor protein β-secretase from human brain.Nature, 402, 533–537 (1999).
Citron, M., β-Secretase as a target for the treatment of Alzheimer's disease.J. Neurosci. Res., 70, 373–379 (2002).
Feldman, K. S. and Sahasrabudhe, K., Ellagitannin Chemistry. Syntheses of tellimagrandin and a dehydrodigalloyl ethercontaining dimeric gallotannin analogue of coriariin A.J. Org. Chem., 64, 209–216 (1999).
Ghosh A. K., Bilcer G., Harwood C., Kawahama R., Shin, D., Hussain, K. A., Hong, L., Loy, J. A., Nguyen, C., Koelsch, G., Ermolieff, J., and Tang, J., Structure-based design: potent inhibition of human brain memapsin 2 (β-secretase).J. Med. Chem., 44, 2865–2868 (2001).
Ghosh, A. K., Shin, D., Downs, D., Koelsch, G., Lin, X., Ermolieff, J., and Tang, J., Design of potent inhibitors for human brain memapsin 2 (β-secretase).J. Am. Chem. Soc., 122, 3522–3523 (2000).
Glenner, G. G. and Wong, C. W., Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.Biochem. Biophys. Res. Commun., 120, 885–890 (1984).
Jeon, S.-Y., Bae, K.-H., Seong, Y.-H., and Song, K.-S., Green tea catechins as a BACE1 (β-secretase) inhibitor.Bioorg. Med. Chem. Lett., 13, 3905–3908 (2003).
Kim, S.-I. and Song, K.-S., 1,2,3,4,6-Pentagalloyl-β-d-glucopyranose, a prolyl endopeptidase inhibitor from Moutan cortex.J. Korean Soc. Agric. Chem. Biotechnol., 43, 158–161 (2000).
Lee, V. M.-Y., Balin, B. J., Otvos, L., and Trojanowski, J. Q., A major subunit of paired helical filaments and derivatized forms of normal tau.Science, 251, 675–678 (1991).
Terry, R. D., Masliah, E., and Hansen, L. A., The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations, in: R. D. Terryet al. (Ed.), Alzheimer Disease, Lippincott, Williams and Wilkins, Philadelphia, pp. 187–206 (1999).
Tung, J. S., Davis D. L., Anderson J. P., Walker D. E., Mamo S., Jewett N., Hom R. K., Sinha S., Thorsett E. D., and John V., Design of substrate-based inhibitors of human β-secretase.J. Med. Chem., 45, 259–262, (2002).
Vassar, R., β-Secretase (BACE) as a drug target for alzheimer's disease.Advanced Drug Delivery Reviews, 54, 1589–1602 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, HJ., Seong, YH., Bae, KH. et al. β-Secretase (BACE1) inhibitors from Sanguisorbae Radix. Arch Pharm Res 28, 799–803 (2005). https://doi.org/10.1007/BF02977345
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02977345